Citations

Clear

2966 citation(s) found for "Go, Ronald S".

STAGED-PKD: An Enriched, Seamless, Two-Stage Study for Venglustat Assessment in ADPKD
Hariri, Ali, Minini, Pascal, Chapman, Arlene B., Horie, Shigeo , Knebelmann, Bertrand , Mrug, Michal , Ong, Albert , Pei, York , Modur, Vijay , Gansevoort, Ron T. , Ong, Albert C M , Perrone, Ronald D. , Ahn, Curie , Torres, Vicente E.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 502-502

10.1681/asn.20203110s1502a Get It

A Post Hoc Analysis of Tolvaptan (TOL) Efficacy and Safety in Slowing Rate of Renal Function Decline in Subjects with Very Late-Stage Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Gansevoort, Ron T. , Chapman, Arlene B., Ouyang, John , Lee, Jennifer , Japes, Hina, Torres, Vicente E. , Perrone, Ronald D. , Wang, Tao

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 490-490

10.1681/asn.20203110s1490c Get It

Volume Progression and Imaging Classification of Polycystic Liver in ADPKD
Bae, Kyongtae T., Tao, Cheng , Feldman, Robert , Chapman, Arlene B., Brosnahan, Godela , Steinman, Theodore I., Braun, William E. , Mrug, Michal , Landsittel, Douglas , Yu, Alan S.L. , Torres, Vicente E. , Perrone, Ronald D. , Bennett, William M. , Harris, Peter C. , Abebe, Kaleab Z

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 500-500

10.1681/asn.20203110s1500c Get It

Overweight and Obesity Are Predictors of Pain in the HALT-PKD Studies
You, Zhiying , Brosnahan, Godela , Miskulin, Dana C. , Steinman, Theodore I., Braun, William E. , Chapman, Arlene B., Chonchol, Michel , Study, HALT-PKD, Wang, Wei Qiang , Gitomer, Berenice Y , Harris, Peter C. , Torres, Vicente E. , Abebe, Kaleab Z , Yu, Alan S.L. , Perrone, Ronald D. , Nowak, Kristen L. , Study, HALT-PKD

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 500-500

10.1681/asn.20203110s1500a Get It

PKD1 Compared with PKD2 Genotype and Cardiac Hospitalizations in the HALT-PKD Studies
You, Zhiying , Brosnahan, Godela , Steinman, Theodore I., Braun, William E. , Chapman, Arlene B., Chonchol, Michel , Steele, Cortney , Gitomer, Berenice Y , Harris, Peter C. , Torres, Vicente E. , Abebe, Kaleab Z , Yu, Alan S.L. , Perrone, Ronald D. , Nowak, Kristen L.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 488-488

10.1681/asn.20203110s1488a Get It

Terlipressin Improves Renal Replacement Therapy-Free Survival in Hepatorenal Syndrome Type 1
Velez, Juan Carlos Q. , Befeler, Alex S. , Kurtz, Ira , Gallegos‐Orozco, Juan F. , Pappas, S. Chris , Jamil, Khurram , Vargas, Hugo E. , Vierling, John Moore

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 15-15

10.1681/asn.20203110s115b Get It

TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy
Youssef, Hossam , Gatto, Rodolfo G. , Pham, Nha Trang Thu, Petersen, Ronald C. , Reichard, R. Ross , Jack, Clifford R. , Whitwell, Jennifer L., Josephs, Keith A. , Jack, Clifford R , Whitwell, Jennifer L , Youseff, Hossam , Machulda, Mary M. , Dickson, Dennis W. , Whitwell, Jennifer

Mayo Clinic

Journal of Alzheimer’s Disease | May 10, 2024 | Volume: 99 | Issue: 3 | Pages: 1023-1032

10.3233/jad-240136 | PMID 38728190 Get It

Background: TAR DNA binding protein 43 (TDP-43) has been shown to be associated with whole hippocampal atrophy in primary age-related tauopathy (PART). It is currently unknown which subregions of the hippocampus are contributing to TDP-43 associated whole hippocampal atrophy in PART. Objective: To identify which specific hippocampal subfield regions are contributing to TDP-43-associated whole hippocampal atrophy in PART. Methods: A total of 115 autopsied cases from the Mayo Clinic Alzheimer Disease Research Center, Neurodegenerative Research Group, and the Mayo Clinic Study of Aging were analyzed. All cases underwent antemortem brain volumetric MRI, neuropathological assessment of the distribution of Aβ (Thal phase), and neurofibrillary tangle (Braak stage) to diagnose PART, as well as assessment of TDP-43 presence/absence in the amygdala, hippocampus and beyond. Hippocampal subfield segmentation was performed using FreeSurfer version 7.4.1. Statistical analyses using logistic regression were performed to assess for associations between TDP-43 and hippocampal subfield volumes, accounting for potential confounders. Results: TDP-43 positive patients ( n = 37, 32%), of which 15/15 were type-α, had significantly smaller whole hippocampal volumes, and smaller volumes of the body and tail of the hippocampus compared to TDP-43 negative patients. Subfield analyses revealed an association between TDP-43 and the molecular layer of hippocampal body and the body of cornu ammonis 1 (CA1), subiculum, and presubiculum regions. There was no association between TDP-43 stage and subfield volumes. Conclusions: Whole hippocampal volume loss linked to TDP-43 in PART is mainly due to volume loss occurring in the molecular layer, CA1, subiculum and presubiculum of the hippocampal body.
Cell-Free DNA to Predict Severe Exacerbations in Chronic Obstructive Pulmonary Disease
Richert, Mary, Balasubramanian, S. , Brower, Ronald W., Bleecker, Eugene R., Meyers, Deborah A. , Ortega, Victor E. , Woodruff, Prescott G. , Curtis, J.L., Kong, Hyesik , Jang, Moon Kyoo , Andargie, Temesgen Ewunetu , Brower, R., Bowler, Russell P. , Christenson, Stephanie A. , O’Neal, Wanda K. , Martínez, Fernando J. , Curtis, J.L., Agbor-Enoh, Sean T.

Mayo Clinic

A101. FULL METAL JACKET TARGETING COPD AND CHRONIC AIRWAYS DISEASE | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A2798-A2798

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2798 Get It

Interim Results From the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH)
Zolty, Ronald , Kingrey, J.F. , Penn, Benjamin G., Sobol, Irina , Sood, Namita , Benza, R.L., Channick, Richard N. , McLaughlin, Vallerie V. , Vachiéry, Jean‐Luc , Zamanian, R.T., Cravets, Matt , Roscigno, R.F., Mottola, David, Parsley, E., Aranda, R., Zisman, Lawrence S. , Investigators, on behalf of the TORREY Study, Sitbon, Olivier , Sahay, Sandeep , Subías, Pilar Escribano , Penn, B., Channick, Richard N. , Chin, Kelly M , Frantz, Robert P. , Hemnes, Anna R. , Howard, Luke , McLaughlin, Vallerie V. , Ghofrani, Hossein Ardeschir

Mayo Clinic

A14. BUILDING LEGO(LAND): LESSONS LEARNED FROM LARGE SCALE CLINICAL TRIALS IN PAH | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1011-A1011

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1011 Get It